— Know what they know.
Not Investment Advice

MSON NASDAQ

Misonix, Inc.
1W: +2.8% 1M: +3.9% 3M: +0.0% 1Y: +133.0% 3Y: +51.0% 5Y: +414.3%
$26.54
Last traded 2021-10-28 — delisted
NASDAQ · Healthcare · Medical - Devices

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$74M +18.5% ▲
5Y CAGR: +26.2%
Gross Profit
$53M +20.4% ▲
5Y CAGR: +27.7%
Operating Income
-$11M +43.1% ▲
Net Income
-$14M +16.9% ▲
EPS (Diluted)
$-0.99 +16.8% ▲
EBITDA
-$6M +61.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$27M$37M$39M$62M$74M
YoY Growth+18.0%+34.5%+5.9%+60.8%+18.5%
Cost of Revenue$8M$10M$12M$19M$21M
Gross Profit$19M$27M$27M$44M$53M
Gross Margin69.9%73.3%70.2%70.0%71.1%
R&D Expenses$2M$4M$4M$5M$5M
SG&A Expenses$24M$25M$30M$58M$59M
Operating Expenses$26M$30M$35M$63M$64M
Operating Income-$7M-$3M-$7M-$19M-$11M
Operating Margin-24.2%-8.0%-19.1%-31.0%-14.9%
Interest Expense$0$0$0$3M$4M
Income Before Tax-$3M-$2M-$7M-$22M-$14M
Tax Expense-$1M$5M$29K-$4M$132K
Net Income-$2M-$8M-$7M-$17M-$14M
Net Margin-6.2%-20.8%-19.0%-27.9%-19.6%
EPS (Diluted)$-0.20$-0.84$-0.79$-1.19$-0.99
EBITDA-$2M-$769K-$6M-$16M-$6M
Shares Outstanding8M9M9M15M15M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms